Zhejiang Shouxiangu Pharm Co (603896) - Total Liabilities

Latest as of March 2026: CN¥927.41 Million CNY ≈ $135.71 Million USD

Based on the latest financial reports, Zhejiang Shouxiangu Pharm Co (603896) has total liabilities worth CN¥927.41 Million CNY (≈ $135.71 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 603896 net assets growth trend to track the company's year-over-year net asset growth rate.

Zhejiang Shouxiangu Pharm Co - Total Liabilities Trend (2012–2025)

This chart illustrates how Zhejiang Shouxiangu Pharm Co's total liabilities have evolved over time, based on quarterly financial data. See Zhejiang Shouxiangu Pharm Co free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Zhejiang Shouxiangu Pharm Co Competitors by Total Liabilities

The table below lists competitors of Zhejiang Shouxiangu Pharm Co ranked by their total liabilities.

Company Country Total Liabilities
Nel ASA
OL:NEL
Norway Nkr1.26 Billion
D I Corp
KO:003160
Korea ₩219.58 Billion
Jtekt India Limited
NSE:JTEKTINDIA
India Rs6.33 Billion
Samhi Hotels Limited
NSE:SAMHI
India Rs20.08 Billion
Beijing Forever Technology Co Ltd
SHE:300365
China CN¥367.07 Million
Shanxi Antai Group Co Ltd
SHG:600408
China CN¥2.94 Billion
Hangzhou Zhongya Machinery Co Ltd
SHE:300512
China CN¥1.05 Billion
SUNIC SYSTEM Co. Ltd
KQ:171090
Korea ₩252.21 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Zhejiang Shouxiangu Pharm Co's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Zhejiang Shouxiangu Pharm Co (603896) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.13 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.41 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.29 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Zhejiang Shouxiangu Pharm Co's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Zhejiang Shouxiangu Pharm Co (2012–2025)

The table below shows the annual total liabilities of Zhejiang Shouxiangu Pharm Co from 2012 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥1.02 Billion
≈ $149.42 Million
+21.97%
2024-12-31 CN¥837.17 Million
≈ $122.50 Million
-16.54%
2023-12-31 CN¥1.00 Billion
≈ $146.78 Million
+5.51%
2022-12-31 CN¥950.67 Million
≈ $139.11 Million
+177.64%
2021-12-31 CN¥342.41 Million
≈ $50.11 Million
-8.27%
2020-12-31 CN¥373.28 Million
≈ $54.62 Million
+121.77%
2019-12-31 CN¥168.31 Million
≈ $24.63 Million
-18.61%
2018-12-31 CN¥206.79 Million
≈ $30.26 Million
+265.38%
2017-12-31 CN¥56.60 Million
≈ $8.28 Million
-67.69%
2016-12-31 CN¥175.17 Million
≈ $25.63 Million
-26.21%
2015-12-31 CN¥237.38 Million
≈ $34.74 Million
+31.56%
2014-12-31 CN¥180.43 Million
≈ $26.40 Million
+64.24%
2013-12-31 CN¥109.85 Million
≈ $16.07 Million
-19.01%
2012-12-31 CN¥135.64 Million
≈ $19.85 Million
--

About Zhejiang Shouxiangu Pharm Co

SHG:603896 China Biotechnology
Market Cap
$423.25 Million
CN¥2.89 Billion CNY
Market Cap Rank
#13102 Global
#3866 in China
Share Price
CN¥14.59
Change (1 day)
-0.41%
52-Week Range
CN¥12.95 - CN¥22.65
All Time High
CN¥56.07
About

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. engages in the selection, cultivation, processing, and sale of medicinal materials in China. It offers Ganoderma lucidum spore powder and brand broken cell wall powder, as well as broken wall Ganoderma lucidum spore powder granules and powder tablets; Tiepi Fengdou granules; and Tiepi Fengdou Ganoderma lucidum extracts. The company offers its products … Read more